What baffles me is that Jason didn't change his
Post# of 30027
Quote:
What baffles me is that Jason didn't change his .20 cent Price Target for year end. How could he have confidence in that if he believes Lympro will only bring in 1 million in 2015?
Did he not give revenue estimates previously? As Warp mentioned I believe earlier, his (JN's) credibility becomes clouded by dumping those kind of figures out there...
Jason eluded to significant "ramping" of the revenue generated in Tanis's post referencing tweets from him here....
http://investorshangout.com/post/view?id=1788211